Innovative agreements: Exploring alternative payment models

By AmerisourceBergen

Learn why payers are embracing contracts that support emerging and complex therapies

Healthcare payers and biopharma companies have increasingly adopted innovative agreements, such as outcomes-based contracts, disease management programs, and subscription models, which aim to improve health outcomes and/or reduce cost. As the industry drives towards value-based pricing, a growing emphasis is being placed on novel payment models, especially for cell and gene therapies.

Watch today to learn:

  • What really matters to payers?
  • What are the most common drivers?
  • The key elements in successful partnerships
  • Upcoming financial products for cell and gene therapies

Enter your information below to access the webinar on demand.